UV Germi (France) Performance
| ALUVI Stock | EUR 2.55 0.06 2.41% |
The entity owns a Beta (Systematic Risk) of -0.59, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning UV Germi are expected to decrease at a much lower rate. During the bear market, UV Germi is likely to outperform the market. At this point, UV Germi SA has a negative expected return of -0.38%. Please make sure to validate UV Germi's potential upside, and the relationship between the jensen alpha and rate of daily change , to decide if UV Germi SA performance from the past will be repeated at some future date.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days UV Germi SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors. ...more
ALUVI |
UV Germi Relative Risk vs. Return Landscape
If you would invest 337.00 in UV Germi SA on September 1, 2024 and sell it today you would lose (82.00) from holding UV Germi SA or give up 24.33% of portfolio value over 90 days. UV Germi SA is generating negative expected returns and assumes 2.878% volatility on return distribution over the 90 days horizon. Simply put, 25% of stocks are less volatile than ALUVI, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
UV Germi Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for UV Germi's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as UV Germi SA, and traders can use it to determine the average amount a UV Germi's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1323
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ALUVI |
Estimated Market Risk
| 2.88 actual daily | 25 75% of assets are more volatile |
Expected Return
| -0.38 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average UV Germi is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of UV Germi by adding UV Germi to a well-diversified portfolio.
UV Germi Fundamentals Growth
ALUVI Stock prices reflect investors' perceptions of the future prospects and financial health of UV Germi, and UV Germi fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ALUVI Stock performance.
| Return On Equity | -0.0619 | |||
| Return On Asset | 0.0204 | |||
| Profit Margin | (0.07) % | |||
| Operating Margin | 0.04 % | |||
| Current Valuation | 7.06 M | |||
| Shares Outstanding | 3.12 M | |||
| Price To Book | 1.13 X | |||
| Price To Sales | 1.37 X | |||
| Revenue | 6.32 M | |||
| EBITDA | (718.12 K) | |||
| Cash And Equivalents | 4.37 M | |||
| Cash Per Share | 1.71 X | |||
| Total Debt | 323.46 K | |||
| Debt To Equity | 14.60 % | |||
| Book Value Per Share | 2.91 X | |||
| Cash Flow From Operations | 97 K | |||
| Earnings Per Share | (0.20) X | |||
| Total Asset | 7.78 M | |||
About UV Germi Performance
Assessing UV Germi's fundamental ratios provides investors with valuable insights into UV Germi's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the UV Germi is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
UV GERMI, Socit anonyme develops and manufactures UV sterilizers for water treatment applications. The company offers its products for applications in the areas of drinking water, waste water, water in public swimming pools, rain water, air, and surfaces, as well as industrial water in food processing, pharmaceutical, and cosmetic industries. UV GERMI operates under Pollution Treatment Controls classification in France and is traded on Paris Stock Exchange. It employs 30 people.Things to note about UV Germi SA performance evaluation
Checking the ongoing alerts about UV Germi for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for UV Germi SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| UV Germi SA generated a negative expected return over the last 90 days | |
| The company reported the revenue of 6.32 M. Net Loss for the year was (869.52 K) with profit before overhead, payroll, taxes, and interest of 2.66 M. | |
| About 47.0% of the company shares are held by company insiders |
- Analyzing UV Germi's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether UV Germi's stock is overvalued or undervalued compared to its peers.
- Examining UV Germi's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating UV Germi's management team can have a significant impact on its success or failure. Reviewing the track record and experience of UV Germi's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of UV Germi's stock. These opinions can provide insight into UV Germi's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for ALUVI Stock Analysis
When running UV Germi's price analysis, check to measure UV Germi's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UV Germi is operating at the current time. Most of UV Germi's value examination focuses on studying past and present price action to predict the probability of UV Germi's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UV Germi's price. Additionally, you may evaluate how the addition of UV Germi to your portfolios can decrease your overall portfolio volatility.